
Sign up to save your podcasts
Or


Based on Podcast App listening data
Dr Stephen Ansell from Mayo Clinic in Rochester, Minnesota, and Dr Brian Hill from Cleveland Clinic Taussig Cancer Institute in Ohio summarize major treatment advances over the past year and review relevant ongoing clinical trials for patients with non-Hodgkin lymphoma.
CME information and select publications here.
Clinical investigators discuss available data guiding the management of systemic mastocytosis and myelofibrosis.
CME information and select publications here.
Clinical investigators discuss available data guiding the management of multiple myeloma.
CME information and select publications here.
Dr Rafael Fonseca from Mayo Clinic in Phoenix, Arizona, discusses datasets from the 2024 ASH meeting on the management of newly diagnosed and relapsed/refractory multiple myeloma.
CME information and select publications here.
Dr Lindsey Roeker from Mayo Clinic in Rochester, Minnesota, discusses recent updates on available and novel treatment strategies for chronic lymphocytic leukemia.
CME information and select publications here.
Dr Carla Casulo from Wilmot Cancer Institute in Rochester, New York, Dr Matthew Matasar from Rutgers Cancer Institute of New Jersey in New Brunswick and Dr Laurie H Sehn from BC Cancer Centre for Lymphoid Cancer in Vancouver discuss recent updates on available and novel treatment strategies for relapsed/refractory follicular lymphoma.
CME information and select publications here.
Dr Jennifer Crombie from the Dana-Farber Cancer Institute in Boston, Massachusetts, reviews available and investigational CD20 x CD3 targeted bispecific antibodies for the treatment of follicular and diffuse large B-cell lymphomas.
CME information and select publications here.
Dr Carla Casulo from Wilmot Cancer Institute in Rochester, New York, Dr Matthew Matasar from Rutgers Cancer Institute of New Jersey in New Brunswick and Dr Laurie H Sehn from BC Cancer Centre for Lymphoid Cancer in Vancouver discuss recent updates on available and novel treatment strategies for relapsed/refractory follicular lymphoma.
CME information and select publications here.
Clinical investigators discuss available data guiding the management of non-Hodgkin lymphoma.
CME information and select publications here.
Dr John P Leonard from Weill Cornell Medicine in New York, New York, reviews data presented at the 2024 ASH Annual Meeting and their implications for the treatment of non-Hodgkin lymphomas.
CME information and select publications here.
From the publisher's feed
Ranked by our users in the last 21 days

317 Listeners

39 Listeners

65 Listeners

31 Listeners

14 Listeners

17 Listeners

13 Listeners

0 Listeners

120 Listeners

57 Listeners

1,157 Listeners

46 Listeners

2 Listeners

366 Listeners

51 Listeners

59 Listeners

51 Listeners

195 Listeners

47 Listeners

30 Listeners

0 Listeners